Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management

Area of Science:

• Cardiology
• Infectious Diseases
• Pathophysiology

Background:

• The global pandemic of severe acute respiratory coronavirus 2 (SARS-CoV-2) has led to Coronavirus Disease 2019 (COVID-19).
• While primarily a respiratory illness, COVID-19 is associated with cardiac complications, including myocarditis, cardiomyopathy, arrhythmias, and cardiac arrest.
• These cardiac manifestations pose a significant burden on healthcare systems worldwide.

Purpose of the Study:

• To review the current understanding of the pathophysiology of COVID-19-related myocarditis.
• To outline the current management strategies for myocarditis in the context of COVID-19.

Main Methods:

• Literature review of existing studies and reports on COVID-19 and cardiac complications.
• Synthesis of information regarding the mechanisms underlying COVID-19-induced myocarditis.
• Analysis of clinical data and treatment guidelines for managing myocarditis.

Main Results:

• COVID-19 can trigger myocarditis through direct viral invasion, immune-mediated injury, or a combination of both.
• Myocarditis in COVID-19 patients presents with a range of symptoms, from mild chest discomfort to severe heart failure and arrhythmias.
• Effective management involves supportive care, anti-inflammatory treatments, and addressing the underlying viral infection.

Conclusions:

• COVID-19 poses a significant risk for developing myocarditis, impacting cardiovascular health globally.
• Understanding the pathophysiology is crucial for timely diagnosis and effective treatment of COVID-19-related myocarditis.
• Prompt and appropriate management can mitigate the adverse cardiac outcomes associated with COVID-19.